| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.047 | 0.3 |